• Pharmapremia
• 10 May, 2018

Historically speaking, Oncology development has been particularly fraught with failure: Likelihood of Approval from Phase 1 “Specializing Matters?” Big players aren’t all created equally Some Companies are having more success in Oncology than other Diseases: Abbvie, Takeda, Roche/Genetech, Merck, Pfizer and Bristol-Myers-Squibb
Read more...